Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L5 pseudogene 34 (RPL5P34) is a processed pseudogene derived from the ribosomal protein L5 (RPL5) gene, which encodes a component of the large ribosomal 60S subunit important for protein synthesis. Pseudogenes like RPL5P34 are dispersed throughout the genome and typically do not encode functional proteins. While some ribosomal protein pseudogenes may be transcribed as noncoding RNAs with potential regulatory roles, there is no evidence of RPL5P34 functioning as a target or playing a role in disease or protein synthesis. The parent gene, RPL5, is well characterized and implicated in ribosome function and rare anemias, but these attributes do not apply to its pseudogene copies[1][3][7]. RPL5P34 is a non-functional pseudogene, not a drug target, receptor, or enzyme. Entries or queries about RPL5P34 as a potential therapeutic target would be considered incorrect; information usually relates to its parent gene, RPL5, which is functional[1][6][7]. No structured pharmacological, disease, or mechanism data exist for RPL5P34.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L5 pseudogene 34 (RPL5P34).